This inventor holds 4 USPTO granted patents. Top assignee: Bn Intellectual Properties, Inc.. Active years: 2020-2022.
Company Filing History:
Years Active: 2020-2022
Title: Paula Pell: Innovator in Pharmaceutical Treatments
Introduction
Paula Pell is a distinguished inventor based in St. Petersburg, FL (US). She has made significant contributions to the field of pharmaceutical formulations, particularly in the treatment of migraine and cluster headaches. With a total of four patents to her name, her work has the potential to improve the quality of life for many patients suffering from these conditions.
Latest Patents
Among her latest patents is a groundbreaking pharmaceutical formulation designed for treating symptoms of migraine and cluster headaches. This innovative treatment involves providing a solution of a serotonin receptor agonist (SRA) in an active mesh nebulizer. The process triggers the formation of a plume of particles, which are then delivered into the lungs of a patient during inhalation. Another notable patent focuses on a method of treating respiratory system tissue. This method includes generating a plume of particles from a nebulizer, inhaling the treating solution, and determining whether a dose has been effectively delivered. The treating solution in this case consists of at least 40% ethyl alcohol by volume.
Career Highlights
Paula Pell's career is marked by her dedication to advancing medical treatments through innovative solutions. Her work at Bn Intellectual Properties, Inc. has positioned her as a key player in the pharmaceutical industry. She has consistently focused on developing effective treatments that address significant health challenges.
Collaborations
Paula has collaborated with notable individuals in her field, including Donald M Pell and Michael P Spuza. These partnerships have contributed to her success and the advancement of her innovative projects.
Conclusion
Paula Pell is a remarkable inventor whose work in pharmaceutical formulations has the potential to transform treatment options for patients with migraine and respiratory issues. Her innovative approaches and dedication to improving healthcare are commendable.